Abiomed EV/Sales
Cos'è EV/Sales di Abiomed?
EV/Sales di Abiomed Inc. è 15.23
Qual è la definizione di EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales di aziende nel Health Care settore su NASDAQ rispetto a Abiomed
Cosa fa Abiomed?
Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Aziende con ev/sales simili a Abiomed
- JPMorgan Claverhouse Investment Trust Plc ha EV/Sales di 15.18
- ICG Enterprise Trust Plc ha EV/Sales di 15.18
- PNE AG ha EV/Sales di 15.19
- Invesco Senior Income Trust ha EV/Sales di 15.19
- Matador Mining ha EV/Sales di 15.21
- Nuveen Preferred & Income Opportunities Fund ha EV/Sales di 15.21
- Abiomed ha EV/Sales di 15.23
- Wheaton Precious Metals ha EV/Sales di 15.24
- CK Infrastructure ha EV/Sales di 15.24
- Oriental Payment ha EV/Sales di 15.25
- MERLIN Properties SOCIMI, S.A ha EV/Sales di 15.26
- Nuveen Credit Strategies Income Fund ha EV/Sales di 15.27
- Whitefield ha EV/Sales di 15.29